HCA Healthcare (NYSE:HCA) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of HCA Healthcare (NYSE:HCAFree Report) from a buy rating to a strong-buy rating in a research report sent to investors on Saturday.

Several other research analysts have also recently commented on HCA. Royal Bank of Canada boosted their price target on shares of HCA Healthcare from $322.00 to $329.00 and gave the stock an outperform rating in a report on Monday, April 29th. Oppenheimer boosted their price target on shares of HCA Healthcare from $330.00 to $345.00 and gave the stock an outperform rating in a report on Monday, April 29th. Cantor Fitzgerald restated an overweight rating and issued a $335.00 target price on shares of HCA Healthcare in a report on Wednesday, April 10th. Raymond James upped their target price on shares of HCA Healthcare from $300.00 to $330.00 and gave the company an outperform rating in a report on Wednesday, January 31st. Finally, Truist Financial upped their target price on shares of HCA Healthcare from $320.00 to $345.00 and gave the company a buy rating in a report on Wednesday, January 31st. Four research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of Moderate Buy and an average target price of $317.00.

Check Out Our Latest Analysis on HCA

HCA Healthcare Price Performance

HCA Healthcare stock opened at $325.15 on Friday. The company’s 50 day simple moving average is $319.79 and its 200-day simple moving average is $303.52. The company has a market capitalization of $85.16 billion, a price-to-earnings ratio of 16.21, a price-to-earnings-growth ratio of 1.50 and a beta of 1.66. HCA Healthcare has a 1 year low of $215.96 and a 1 year high of $335.83. The company has a debt-to-equity ratio of 29.26, a quick ratio of 1.02 and a current ratio of 1.16.

HCA Healthcare (NYSE:HCAGet Free Report) last announced its quarterly earnings data on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, beating analysts’ consensus estimates of $5.01 by $0.35. The firm had revenue of $17.34 billion during the quarter, compared to analysts’ expectations of $16.81 billion. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. The business’s quarterly revenue was up 11.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $4.93 earnings per share. As a group, equities research analysts expect that HCA Healthcare will post 20.79 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Friday, June 14th will be issued a $0.66 dividend. The ex-dividend date of this dividend is Friday, June 14th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.81%. HCA Healthcare’s dividend payout ratio is presently 13.16%.

HCA Healthcare declared that its Board of Directors has initiated a share buyback plan on Tuesday, January 30th that authorizes the company to repurchase $6.00 billion in shares. This repurchase authorization authorizes the company to reacquire up to 7.4% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s leadership believes its stock is undervalued.

Insider Activity at HCA Healthcare

In related news, SVP Chad J. Wasserman sold 344 shares of the stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $321.97, for a total value of $110,757.68. Following the sale, the senior vice president now directly owns 2,452 shares of the company’s stock, valued at approximately $789,470.44. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In other HCA Healthcare news, SVP Chad J. Wasserman sold 344 shares of the firm’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $321.97, for a total transaction of $110,757.68. Following the sale, the senior vice president now directly owns 2,452 shares of the company’s stock, valued at approximately $789,470.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Chad J. Wasserman sold 876 shares of the firm’s stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total transaction of $289,299.00. Following the sale, the senior vice president now directly owns 1,576 shares in the company, valued at $520,474. The disclosure for this sale can be found here. In the last three months, insiders have sold 13,617 shares of company stock valued at $4,321,986. Insiders own 1.70% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of HCA. Allworth Financial LP lifted its holdings in shares of HCA Healthcare by 3.1% during the 3rd quarter. Allworth Financial LP now owns 2,182 shares of the company’s stock worth $537,000 after acquiring an additional 65 shares during the period. Cozad Asset Management Inc. raised its holdings in HCA Healthcare by 0.4% in the third quarter. Cozad Asset Management Inc. now owns 33,244 shares of the company’s stock valued at $8,177,000 after buying an additional 139 shares during the period. Tokio Marine Asset Management Co. Ltd. raised its holdings in HCA Healthcare by 6.2% in the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 4,348 shares of the company’s stock valued at $1,070,000 after buying an additional 253 shares during the period. Hartford Funds Management Co LLC raised its holdings in HCA Healthcare by 9.4% in the third quarter. Hartford Funds Management Co LLC now owns 1,325 shares of the company’s stock valued at $326,000 after buying an additional 114 shares during the period. Finally, Machina Capital S.A.S. purchased a new position in HCA Healthcare in the third quarter valued at approximately $946,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Company Profile

(Get Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Further Reading

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.